Position
Renaissance Technologies in CareDx, Inc.
Back to the book · All holders of CDNA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $13.2M$17.36 → $28.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.11M | $20.8M | — | — | — | 0.0% |
| Q1 2026 | 1.18M | $20.6M | $17.36 | −$1.64M | $1.37M | 0.0% |
| Q2 2026 | 1.24M | $35.4M | $28.50 | $13.2M | $1.67M | 0.0% |